Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average

Core Viewpoint - Adma Biologics (ADMA) shows potential as a strong stock pick due to its recent technical performance and positive earnings revisions [1][2][3] Technical Analysis - ADMA has surpassed the 200-day moving average, indicating a long-term bullish trend [1] - The stock has increased by 17.4% over the past four weeks, reflecting positive momentum [2] Earnings Estimates - There has been one upward revision in earnings estimates for the current fiscal year, with no downward revisions, suggesting confidence in the company's performance [3] - The consensus estimate for ADMA has also increased, further supporting the bullish outlook [3] Market Position - ADMA is currently rated as a Zacks Rank 2 (Buy), indicating strong potential for continued growth [2]